Apte, A.; Dutta Dey, P.; Julakanti, S.R.; Midura-Kiela, M.; Skopp, S.M.; Canchis, J.; Fauser, T.; Bardill, J.; Seal, S.; Jackson, D.M.;
et al. Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice. Pharmaceutics 2024, 16, 1573.
https://doi.org/10.3390/pharmaceutics16121573
AMA Style
Apte A, Dutta Dey P, Julakanti SR, Midura-Kiela M, Skopp SM, Canchis J, Fauser T, Bardill J, Seal S, Jackson DM,
et al. Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice. Pharmaceutics. 2024; 16(12):1573.
https://doi.org/10.3390/pharmaceutics16121573
Chicago/Turabian Style
Apte, Anisha, Pujarini Dutta Dey, Srisaianirudh Reddy Julakanti, Monica Midura-Kiela, Stacy M. Skopp, Jimena Canchis, Tobias Fauser, James Bardill, Sudipta Seal, David M. Jackson,
and et al. 2024. "Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice" Pharmaceutics 16, no. 12: 1573.
https://doi.org/10.3390/pharmaceutics16121573
APA Style
Apte, A., Dutta Dey, P., Julakanti, S. R., Midura-Kiela, M., Skopp, S. M., Canchis, J., Fauser, T., Bardill, J., Seal, S., Jackson, D. M., Ghishan, F. K., Kiela, P. R., Zgheib, C., & Liechty, K. W.
(2024). Oral Delivery of miR146a Conjugated to Cerium Oxide Nanoparticles Improves an Established T Cell-Mediated Experimental Colitis in Mice. Pharmaceutics, 16(12), 1573.
https://doi.org/10.3390/pharmaceutics16121573
